Cite
MLA Citation
Keith Kaye et al.. “1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections.” Open forum infectious diseases, vol. 5, n.d., p. S409. http://access.bl.uk/ark:/81055/vdc_100095535500.0x000007